|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date31 Dec 1985 |
|
MechanismPhosphodiesterases, 3',5'-cyclic nucleotide (PDEs) inhibitors [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date30 Aug 1984 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date02 Nov 1960 |
100 Clinical Results associated with Clinect Pty Ltd.
0 Patents (Medical) associated with Clinect Pty Ltd.
100 Deals associated with Clinect Pty Ltd.
100 Translational Medicine associated with Clinect Pty Ltd.